ScholarIQanswers from OpenAlex & ORCID
Bart O. Roep
ResearcherPublications, citations & collaboration network
Bart O. Roep is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Bart O. Roep have?
ScholarIQindexed works
Bart O. Roep has 459 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Bart O. Roep have?
ScholarIQcitation count
Bart O. Roep has 23,400 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Bart O. Roep?
ScholarIQh-index
Bart O. Roep has an h-index of 84 in OpenAlex.
What is the i10-index of Bart O. Roep?
ScholarIQi10-index
Bart O. Roep has an i10-index of 277 in OpenAlex.
What is the ORCID of Bart O. Roep?
ScholarIQorcid
The ORCID for Bart O. Roep is on the source record.
What is the OpenAlex record for Bart O. Roep?
ScholarIQopenalex
The OpenAlex for Bart O. Roep is on the source record.
What are the most-cited papers on Bart O. Roep?
ScholarIQmost cited works
Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial
Pieter F. de Groot, Tanja Nikolic, Silvia Pellegrini, Valeria Sordi, Sultan Imangaliyev, Elena Rampanelli, Nordin M.J. Hanssen, Ilias Attaye, Guido J. Bakker, Gaby Duinkerken, Antoinette M. Joosten, Andrei Prodan, Evgeni Levin, Han Levels, Bartjan Potter van Loon, Arianne van Bon, C. van der Blij-de Brouwer, Sytze van Dam, Suat Şimşek, Daniël H. van Raalte, Frank Stam, Victor E. A. Gerdes, Roel P.L.M. Hoogma, Martin Diekman, Martin N. Gerding, Cees Rustemeijer, Bernadette S. de Bakker, Joost Hoekstra, Aeilko H. Zwinderman, Jacques Bergman, F. Holleman, Lorenzo Piemonti, Willem M. de Vos, Bart O. Roep, Max Nieuwdorp
A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk
María J. Redondo, Susan Geyer, Andrea K. Steck, Seth A. Sharp, John M. Wentworth, Michael N. Weedon, Peter A. Antinozzi, Jay M. Sosenko, Mark A. Atkinson, Alberto Pugliese, Richard A. Oram, Type 1 Diabetes TrialNet Study Group, Peter A. Antinozzi, Mark A. Atkinson, Manuela Battaglia, Dorothy J. Becker, P. J. Bingley, Emanuele Bosi, Jan C. Buckner, Peter G. Colman, Peter A. Gottlieb, Kevan C. Herold, Richard A. Insel, Tom Kay, Mikael Knip, Jennifer B. Marks, Antoinette Moran, James L. Palmer, Mark Peakman, Louis H. Philipson, Alberto Pugliese, P. Raskin, Henry Rodriguez, Bart O. Roep, William E. Russell, Desmond Schatz, Diane K. Wherrett, Darrell M. Wilson, William E. Winter, Anette‐Gabriele Ziegler, Christophe Benoıst, J.J. Blum, Peter Chase, Michael Clare‐Salzler, Raphael Clynes, George S. Eisenbarth, C. Garrison Fathman, Gilman D. Grave, Bernhard J. Hering, Francine Kaufman, Ellen Leschek, J. Mahon, Kirsti Näntö‐Salonen, Gerald T. Nepom, Tihamer Orban, Robertson Parkman, Mark D. Pescovitz, John Peyman, Maria Grazia Roncarolo, Olli Simell, Robert Sherwin, Mark Siegelman, Andrea K. Steck, James W. Thomas, Massimo Trucco, J. Richard Wagner, Carla J. Greenbaum, Katarzyna Bourcier, Richard A. Insel, Jeffrey P. Krischer, Ellen Leschek, Lisa Rafkin, Lisa M. Spain, Catherine C. Cowie, Mary A. Foulkes, Heidi Krause‐Steinrauf, John M. Lachin, Saúl Malozowski, John Peyman, J P Ridge, Peter J. Savage, Jay S. Skyler, Stephanie J. Zafonte, Norma S. Kenyon, Irene Santiago, Jay M. Sosenko, Brian N. Bundy, Michael Abbondondolo, Timothy E. Adams, Darlene Amado, Ilma Asif, Matthew Boonstra, Brian N. Bundy, Cristina Burroughs, David Cuthbertson, Mary Deemer, Christopher Eberhard, Steve Fiske, Julie Ford, Jennifer Garmeson